Skip to main content

Thermo Fisher Scientific statistics

  • TMO · NYSE
  • Instruments
  • Life Sciences Tools & Services
  • S&P 500
$700.22+0.11%Close 13 Nov 2026

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

Enterprise value$294.9B
EV / EBITDA25.48
EV / sales6.23

Share price

Latest close$700.22
Day's change+0.1%
52-week high$727.56
52-week low$435.27
From 52-week high−3.8%
Return · 1 month+1.5%
Return · 3 months+11.6%
Return · year to date+20.8%
Return · 1 year+19.1%
Beta · 1 year against the S&P 5000.69
50-day average$670.62
200-day average$555.37
RSI 1453.7
Average volume · 20 sessions2.2M

Margins and returns

For fiscal 2025, as filed.

Gross margin40.9%
Operating margin17.4%
Net margin15.0%
Free cash flow margin14.1%
Return on equity13.0%
Return on assets6.9%
Return on invested capital8.2%
Return on capital employed8.6%
Stock-based compensation / revenue0.7%

Financial position

At the end of fiscal 2025.

Cash and equivalents$9.85B
Total debt$40.85B
Net debt$30.75B
Current ratio1.89
Debt / equity0.76
Net debt / EBITDA2.92
Interest coverage5.46

Shares and dividends

For fiscal 2025, as filed.

Diluted shares378M
Net share repurchases$3.00B
Dividends per share$1.72
Dividend payout9.5%

Taxes

For fiscal 2025, as filed.

Income tax expense$547.0M
Effective tax rate7.5%

TMO in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.